Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Jiangxi Lijia Pharmaceutical Co., Ltd. is a pharmaceutical and nutraceutical company headquartered in Zhangshu, Jiangxi Province, China. Founded in 2001, the company specializes in the development, manufacturing, and distribution of a diverse portfolio of over 60 products, including generic chemical drugs and dietary supplements. It is particularly recognized for its probiotics line, which includes Bifidobacterium-based formulations for gastrointestinal health, and its range of vitamin and mineral supplements like Calcium Carbonate with Vitamin D3. The company operates a GMP-certified manufacturing facility and has established a robust sales network spanning more than 20 provinces across China. Jiangxi Lijia has engaged in strategic partnerships with biotechnology firms to enhance its product offerings and maintain its competitive edge in the domestic market.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Jiangxi Lijia Pharmaceutical.